Critically ill patients with community-onset intraabdominal infections: Influence of healthcare exposure on resistance rates and mortality

The concept of healthcare-associated infections (as opposed to hospital-acquired infections) in intraabdominal infections (IAIs) is scarcely supported by data in the literature. The aim of the present study was to analyse community-onset IAIs (non-postoperative/non-nosocomial) in patients admitted t...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 14; no. 9; p. e0223092
Main Authors Maseda, Emilio, Ramírez, Sofía, Picatto, Pedro, Peláez-Peláez, Eva, García-Bernedo, Carlos, Ojeda-Betancur, Nazario, Aguilar, Gerardo, Forés, Beatriz, Solera-Marín, Jorge, Aliaño-Piña, María, Tamayo, Eduardo, Ramasco, Fernando, García-Álvarez, Raquel, González-Lisorge, Ada, Giménez, María-José, Suárez-de-la-Rica, Alejandro
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 26.09.2019
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The concept of healthcare-associated infections (as opposed to hospital-acquired infections) in intraabdominal infections (IAIs) is scarcely supported by data in the literature. The aim of the present study was to analyse community-onset IAIs (non-postoperative/non-nosocomial) in patients admitted to intensive care units (ICUs), to investigate differences in resistance patterns linked to healthcare exposure and mortality-associated factors. A one-year prospective observational study (17 Spanish ICUs) was performed distributing cases as healthcare-associated infections (HCAI), community-acquired infections (CAI) and immunocompromised patients (ICP). Bacteria producing extended-spectrum β-lactamases (ESBL) and/or carbapenemase (CPE), high-level aminoglycoside- and/or methicillin- and/or vancomycin- resistance were considered antimicrobial resistant (AMR). Mortality-associated factors were identified by regression multivariate analysis. Of 345 patients included (18.8% HCAI, 6.1% ICP, 75.1% CAI), 51.6% presented generalized peritonitis; 32.5% were >75 years (55.4% among HCAI). Overall, 11.0% cases presented AMR (7.0% ESBL- and/or CPE), being significantly higher in HCAI (35.4%) vs. CAI (5.8%) (p<0.001) vs. ICP (0%) (p = 0.003). Overall 30-day mortality was 14.5%: 23.1% for HCAI and 11.6% for CAI (p = 0.016). Mortality (R2 = 0.262, p = 0.021) was positively associated with age >75 years (OR = 6.67, 95%CI = 2.56-17.36,p<0.001), Candida isolation (OR = 3.05, 95%CI = 1.18-7.87,p = 0.022), and SAPS II (per-point, OR = 1.08, 95%CI = 1.05-1.11, p<0.001) and negatively with biliary infections (OR = 0.06, 95%CI = 0.01-0.48,p = 0.008). In this study, the antimicrobial susceptibility pattern of bacteria isolated from patients with healthcare contact was shifted to resistance, suggesting the need for consideration of the healthcare category (not including hospital-acquired infections) for severe IAIs. 30-day mortality was positively related with age >75 years, severity and Candida isolation but not with AMR.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Undefined-2
Membership of the HELP study and the Perioperative Infection Research Group is provided in the Acknowledgments.
Competing Interests: E.M. has served as speaker for Merck, Sharp & Dohme (MSD), Pfizer and Astellas; and has received educational grants from Astellas. F.R. has served as speaker for MSD. G.A. has served as speaker for MSD, Astellas, Gilead, and Pfizer and received educational grants from Astellas, Pfizer and MSD. M-JG is employee of PRISM-AG and has received an educational grant from Fundación Micellium para el Desarrollo y Difusión del Conocimiento Científico (Valencia, Spain). The remaining authors have disclosed that they do not have any potential conflicts of interest. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0223092